Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$1.44 - $3.98 $148,374 - $410,091
-103,038 Closed
0 $0
Q4 2021

Feb 01, 2022

SELL
$4.99 - $7.46 $111,915 - $167,312
-22,428 Reduced 17.88%
103,038 $514,000
Q3 2021

Nov 01, 2021

SELL
$7.16 - $9.69 $71,600 - $96,900
-10,000 Reduced 7.38%
125,466 $887,000
Q2 2021

Jul 29, 2021

BUY
$6.23 - $10.03 $31,150 - $50,150
5,000 Added 3.83%
135,466 $1.26 Million
Q1 2021

Apr 20, 2021

BUY
$8.81 - $16.96 $272,845 - $525,251
30,970 Added 31.13%
130,466 $1.21 Million
Q4 2020

Jan 25, 2021

SELL
$8.5 - $12.85 $173,553 - $262,371
-20,418 Reduced 17.03%
99,496 $881,000
Q3 2020

Oct 23, 2020

BUY
$9.57 - $27.05 $762,374 - $2.15 Million
79,663 Added 197.92%
119,914 $1.39 Million
Q2 2020

Jul 10, 2020

SELL
$7.14 - $31.69 $1.34 Million - $5.96 Million
-188,009 Reduced 82.37%
40,251 $1.08 Million
Q1 2020

May 14, 2020

SELL
$2.98 - $14.09 $1.02 Million - $4.83 Million
-342,540 Reduced 60.01%
228,260 $1.7 Million
Q4 2019

Feb 03, 2020

SELL
$1.97 - $3.72 $101,455 - $191,580
-51,500 Reduced 8.28%
570,800 $1.88 Million
Q3 2019

Oct 17, 2019

SELL
$2.05 - $3.02 $54,324 - $80,030
-26,500 Reduced 4.08%
622,300 $1.28 Million
Q2 2019

Aug 20, 2019

SELL
$2.29 - $4.1 $99,844 - $178,759
-43,600 Reduced 6.3%
648,800 $1.92 Million
Q1 2019

Apr 23, 2019

BUY
$3.34 - $5.1 $371,742 - $567,630
111,300 Added 19.15%
692,400 $2.55 Million
Q4 2018

Feb 08, 2019

BUY
$3.89 - $6.11 $2.26 Million - $3.55 Million
581,100 New
581,100 $2.32 Million

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Defender Capital, Llc. Portfolio

Follow Defender Capital, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Defender Capital, Llc. with notifications on news.